Le Lézard
Classified in: Health
Subject: MISCELLANEOUS

Extendicare Announces January 2018 Dividend of C$0.04 per Share


MARKHAM, Ontario, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX:EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of January 2018, which is payable on February 15, 2018 to shareholders of record at the close of business on January 31, 2018. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).

Extendicare has a Dividend Reinvestment Plan (the "DRIP"), which provides Canadian resident holders of Common Shares with the opportunity to increase their respective investments at a 3% discount to the volume weighted average trading price of the Common Shares on the TSX for the five trading days immediately preceding the dividend payment date. A copy of the DRIP package is available under the investors section of Extendicare's website.

ABOUT EXTENDICARE
Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 115 operated senior care and living centres (66 owned/49 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors' population in Canada. Our qualified and highly trained workforce of 23,800 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.

Forward-looking Statements
Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words "anticipate", "believe", "estimate", "expect", "intend", "objective", "plan", "project", "will" or other similar expressions or the negative thereof. Forward-looking statements reflect management's beliefs and assumptions and are based on information currently available, and Extendicare assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Extendicare to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare's forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare's website at www.extendicare.com.

For further information, contact:
Jillian E. Fountain
Corporate Secretary
Phone:  (905) 470-5534; Fax: (905) 470-4003
Email:  [email protected]
www.extendicare.com 


These press releases may also interest you

at 13:25
Bayer will present Kerendia® (finerenone) data from its comprehensive clinical trial program in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in addition to data from FINEARTS-HF, the ongoing randomized, double-blind,...

at 13:22
The San Francisco Business Times has named Gladstone Institutes President Deepak Srivastava, MD, as one of the Most Admired CEOs among Bay Area businesses and nonprofits. In an article now appearing in the weekly publication, Srivastava is noted for...

at 13:00
The "PEGylated Proteins Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and is projected to reach $15.9 billion by the end of...

at 13:00
Associates of Cape Cod Inc. (ACC), a Seikagaku Group Company, is marking 50 years of innovation and safeguarding public health with a new brand identity, embodying the company's enduring legacy and forward-looking vision. Along with a new logo, the...

at 12:58
Dr. Paul Carey DDS, a distinguished figure in the medical community, is proud to announce the continuation of the Dr. Paul Carey Scholarship for Medical Students, an esteemed scholarship program aimed at supporting aspiring medical professionals in...

at 12:51
Dr. Scott Kamelle, a trailblazer in the realm of robotic surgery, begins his work with the highly anticipated Da Vinci 5 robotic surgery system, marking a monumental advancement in surgical precision, efficiency, and patient care. With an array of...



News published on and distributed by: